NCT03162536 2025-09-08ARQ 531-101ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)Phase 1/2 Active not recruiting190 enrolled
NCT01063907 2024-04-25A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple MyelomaKyowa Kirin Co., Ltd.Phase 1/2 Completed95 enrolled 13 charts
NCT01345019 2022-11-08Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple MyelomaAmgenPhase 3 Completed1,718 enrolled 22 charts
NCT01435720 2014-09-11Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL)Senesco Technologies, Inc.Phase 1/2 Unknown15 enrolled